Hernan Levett
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Hernan Levett is currently Director at Versameb AG and Chief Financial Officer at BioVersys AG, both positions started in 2023.
Former roles include Chief Financial Officer at Spexis Ltd. from 2019 to 2023, Head-Group Controlling at Acino Pharma AG, Chief Financial Officer at Novartis Chile SA, Vice President-Finance at InterMune International AG, and Chief Financial & Accounting Officer at Altamira Therapeutics Ltd. from 2017 to 2019.
Education includes an undergraduate degree from Universidad de Buenos Aires.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVERSYS AG -.--% | 2025-12-30 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| BIOVERSYS AG | Director of Finance/CFO | 2023-10-31 |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Director/Board Member | 2023-07-10 |
| Companies | Position | End |
|---|---|---|
| SPEXIS AG | Director of Finance/CFO | 2023-11-30 |
| ALTAMIRA THERAPEUTICS LTD. | Director of Finance/CFO | 2019-10-30 |
Novartis Chile SA | Director of Finance/CFO | - |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Director of Finance/CFO | - |
Acino Pharma AG
Acino Pharma AG Pharmaceuticals: MajorHealth Technology Develops and manufactures oral modified release pharmaceuticals, trans dermal patches and biodegradable implants | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Acino Pharma AG
Acino Pharma AG Pharmaceuticals: MajorHealth Technology Develops and manufactures oral modified release pharmaceuticals, trans dermal patches and biodegradable implants | Health Technology |
Novartis Chile SA | |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
BioVersys AG
BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions